Hospitalizations and Deaths Caused by Methicillin-ResistantStaphylococcus aureus, United States, 1999–2005
Top Cited Papers
Open Access
- 1 December 2007
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (12) , 1840-1846
- https://doi.org/10.3201/eid1312.070629
Abstract
Hospital-acquired infections with Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA) infections, are a major cause of illness and death and impose serious economic costs on patients and hospitals. However, the recent magnitude and trend of these infections have not been reported. We used national hospitalization and resistance data to estimate the annual number of hospitalizations and deaths associated with S. aureus and MRSA from 1999 through 2005. During this period, the estimated number of S. aureus–related hospitalizations increased 62%, from 294,570 to 477,927, and the estimated number of MRSA-related hospitalizations more than doubled, from 127,036 to 278,203. Our findings suggest that S. aureus and MRSA should be considered a national priority for disease control.Keywords
This publication has 41 references indexed in Scilit:
- Skin and Soft Tissue Infections Caused by Methicillin-ResistantStaphylococcus aureusUSA300 CloneEmerging Infectious Diseases, 2007
- Community-associated Methicillin-resistantStaphylococcus aureusIsolates and Healthcare-Associated Infections1Emerging Infectious Diseases, 2007
- Staphylococcus aureus–associated Skin and Soft Tissue Infections in Ambulatory CareEmerging Infectious Diseases, 2006
- Methicillin-ResistantS. aureusInfections among Patients in the Emergency DepartmentNew England Journal of Medicine, 2006
- Methicillin-ResistantStaphylococcus aureusDisease in Three CommunitiesNew England Journal of Medicine, 2005
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- The Impact of Antimicrobial Resistance on Health and Economic OutcomesClinical Infectious Diseases, 2003
- Antimicrobial Resistance in Key Bloodstream Bacterial Isolates: Electronic Surveillance with The Surveillance Network Database‐‐USAClinical Infectious Diseases, 1999
- Nosocomial infections in medical intensive care units in the United StatesCritical Care Medicine, 1999
- The Economic Impact of Staphylococcus aureus Infection in New York City HospitalsEmerging Infectious Diseases, 1999